151 related articles for article (PubMed ID: 3149183)
1. The distribution of lead in human hemopoietic tissue and spongy bone after lead poisoning and Ca-EDTA chelation therapy. Observations made by atomic absorption spectroscopy, laser microbeam mass analysis and electron microbeam X-ray analysis.
Flood PR; Schmidt PF; Wesenberg GR; Gadeholt H
Arch Toxicol; 1988; 62(4):295-300. PubMed ID: 3149183
[TBL] [Abstract][Full Text] [Related]
2. Removing lead from bone: clinical implications of bone lead stores.
Wedeen RP
Neurotoxicology; 1992; 13(4):843-52. PubMed ID: 1302310
[TBL] [Abstract][Full Text] [Related]
3. Management of childhood lead poisoning: a survey.
Glotzer DE; Bauchner H
Pediatrics; 1992 Apr; 89(4 Pt 1):614-8. PubMed ID: 1313555
[TBL] [Abstract][Full Text] [Related]
4. Lead mobilization during calcium disodium ethylenediaminetetraacetate chelation therapy in treatment of chronic lead poisoning.
Sánchez-Fructuoso AI; Cano M; Arroyo M; Fernández C; Prats D; Barrientos A
Am J Kidney Dis; 2002 Jul; 40(1):51-8. PubMed ID: 12087561
[TBL] [Abstract][Full Text] [Related]
5. Effect of chelate treatments on kidney, bone and brain lead levels of lead-intoxicated mice.
Jones MM; Basinger MA; Gale GR; Atkins LM; Smith AB; Stone A
Toxicology; 1994 Apr; 89(2):91-100. PubMed ID: 8197593
[TBL] [Abstract][Full Text] [Related]
6. Reducing bone lead content by chelation treatment in chronic lead poisoning: an in vivo X-ray fluorescence and bone biopsy study.
Batuman V; Wedeen RP; Bogden JD; Balestra DJ; Jones K; Schidlovsky G
Environ Res; 1989 Feb; 48(1):70-5. PubMed ID: 2492468
[TBL] [Abstract][Full Text] [Related]
7. Impacts of lead exposure and chelation therapy on bone metabolism during different developmental stages of rats.
Zhang Y; Zhou L; Li S; Liu J; Sun S; Ji X; Yan C; Xu J
Ecotoxicol Environ Saf; 2019 Nov; 183():109441. PubMed ID: 31404725
[TBL] [Abstract][Full Text] [Related]
8. Ascorbic acid and EDTA treatment of lead toxicity in rats.
Goyer RA; Cherian MG
Life Sci; 1979 Jan; 24(5):433-8. PubMed ID: 107387
[No Abstract] [Full Text] [Related]
9. Atomic absorption determination of lead in blood and urine in the presence of EDTA.
Zinterhofer LJ; Jatlow PI; Fappiano A
J Lab Clin Med; 1971 Oct; 78(4):664-74. PubMed ID: 5000359
[No Abstract] [Full Text] [Related]
10. Lead elimination of ICRF 158 in rats after chronic lead exposure.
Witting U; Hultsch E
Int Arch Occup Environ Health; 1981; 48(1):89-98. PubMed ID: 6783552
[TBL] [Abstract][Full Text] [Related]
11. Clinical applications of L-line X-ray fluorescence to estimate bone lead values in lead-poisoned young children and in children, teenagers, and adults from lead-exposed and non-lead-exposed suburban communities in the United States.
Rosen JF
Toxicol Ind Health; 1997; 13(2-3):211-8. PubMed ID: 9200789
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two heavy metal chelators for treatment of lead toxicosis in cockatiels.
Denver MC; Tell LA; Galey FD; Trupkiewicz JG; Kass PH
Am J Vet Res; 2000 Aug; 61(8):935-40. PubMed ID: 10951987
[TBL] [Abstract][Full Text] [Related]
13. Chronic industrial exposure to lead in 63 subjects. II. Evaluation of chelation therapy.
Strickland GT; Hwang YF; Chang NK; Blackwell RQ
Southeast Asian J Trop Med Public Health; 1976 Dec; 7(4):569-74. PubMed ID: 828980
[TBL] [Abstract][Full Text] [Related]
14. Individual and combined effect of meso-2,3-dimercaptosuccinic acid and allicin on blood and tissue lead content in mice.
Aslani MR; Najarnezhad V; Mohri M
Planta Med; 2010 Feb; 76(3):241-4. PubMed ID: 19764011
[TBL] [Abstract][Full Text] [Related]
15. Chelation therapy in lead nephropathy.
Morgan JM
South Med J; 1975 Aug; 68(8):1001-6. PubMed ID: 125923
[TBL] [Abstract][Full Text] [Related]
16. Two men with lead poisoning.
St George IM
N Z Med J; 1970 May; 71(456):294-7. PubMed ID: 4988850
[No Abstract] [Full Text] [Related]
17. Zinc supplementation of chelation therapy in saturnism. Preliminary study.
Bădulici S; Chirilă M
Rom J Intern Med; 1992; 30(3):211-5. PubMed ID: 1475600
[TBL] [Abstract][Full Text] [Related]
18. Effects of calcium disodium versenate (CaNa2EDTA) chelation in moderate childhood lead poisoning.
Markowitz ME; Bijur PE; Ruff H; Rosen JF
Pediatrics; 1993 Aug; 92(2):265-71. PubMed ID: 8337028
[TBL] [Abstract][Full Text] [Related]
19. Influence of chelation therapy on acute lead intoxication in rats.
Hofmann U; Segewitz G
Arch Toxicol; 1975 Nov; 34(3):213-25. PubMed ID: 1243621
[TBL] [Abstract][Full Text] [Related]
20. Chelation in metal intoxication. XIII. Polyaminocarboxylic acids as chelators in lead poisoning.
Tandon SK; Behari JR; Singh S
Bull Environ Contam Toxicol; 1983 May; 30(5):552-8. PubMed ID: 6407551
[No Abstract] [Full Text] [Related]
[Next] [New Search]
